Glucose-dependent leukocyte activation in patients with type 2 diabetes mellitus, familial combined hyperlipidemia and healthy controls.

[1]  T. Njo,et al.  Leukocyte cell population data (volume conductivity scatter) in postprandial leukocyte activation , 2013, International journal of laboratory hematology.

[2]  J. Jukema,et al.  Erythrocyte-Bound Apolipoprotein B in Relation to Atherosclerosis, Serum Lipids and ABO Blood Group , 2013, PloS one.

[3]  Stacy R. Oliver,et al.  Fasting Glucose Level Modulates Cell Surface Expression of CD11b and CD66b in Granulocytes and Monocytes of Patients With Type 2 Diabetes , 2013, Journal of Investigative Medicine.

[4]  P. Libby.  Inflammation in Atherosclerosis , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[5]  S. Twigg,et al.  Mesangial cell-derived factors alter monocyte activation and function through inflammatory pathways: possible pathogenic role in diabetic nephropathy. , 2009, American journal of physiology. Renal physiology.

[6]  D. Gómez-Garre,et al.  Ezetimibe reduces plaque inflammation in a rabbit model of atherosclerosis and inhibits monocyte migration in addition to its lipid‐lowering effect , 2009, British journal of pharmacology.

[7]  K. Frayn,et al.  Leukocyte Activation by Triglyceride-Rich Lipoproteins , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[8]  T. Rabelink,et al.  Effects of rosuvastatin on postprandial leukocytes in mildly hyperlipidemic patients with premature coronary sclerosis. , 2006, Atherosclerosis.

[9]  A. Stalenhoef,et al.  Role of Insulin Resistance in Familial Combined Hyperlipidemia , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[10]  B. Fagerberg,et al.  Monocytic expression of CD14 and CD18, circulating adhesion molecules and inflammatory markers in women with diabetes mellitus and impaired glucose tolerance , 2004, Diabetologia.

[11]  T. Rabelink,et al.  Activation of leukocytes by postprandial lipemia in healthy volunteers. , 2004, Atherosclerosis.

[12]  Shing‐Jong Lin,et al.  Carvedilol Inhibits Tumor Necrosis Factor-&agr;–Induced Endothelial Transcription Factor Activation, Adhesion Molecule Expression, and Adhesiveness to Human Mononuclear Cells , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[13]  T. Rabelink,et al.  Increased expression of activation markers on monocytes and neutrophils in type 2 diabetes. , 2004, The Netherlands journal of medicine.

[14]  M. Sampson,et al.  Monocyte and Neutrophil Adhesion Molecule Expression During Acute Hyperglycemia and After Antioxidant Treatment in Type 2 Diabetes and Control Patients , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[15]  E. Feskens,et al.  Glucose tolerance and mortality: comparison of WHO and American Diabetic Association diagnostic criteria , 1999, The Lancet.

[16]  G. Specchia,et al.  Clinical and angiographic correlates of leukocyte activation in unstable angina. , 1995, Journal of the American College of Cardiology.

[17]  N. Tuzuner,et al.  Beta glucan induces proliferation and activation of monocytes in peripheral blood of patients with advanced breast cancer. , 2007, International immunopharmacology.

[18]  R. Češka,et al.  Atorvastatin reduces expression of leukocyte adhesion molecules in patients with hypercholesterolemia. , 2003, Atherosclerosis.

[19]  C. Weber.  Novel mechanistic concepts for the control of leukocyte transmigration: specialization of integrins, chemokines, and junctional molecules , 2002, Journal of Molecular Medicine.

[20]  B Kirchhof,et al.  Leukocyte-mediated endothelial cell injury and death in the diabetic retina. , 2001, The American journal of pathology.